Reducing blood cancer risks
Study finds diabetes drug metformin may inhibit the expansion of specific mutant stem cells
Three regenerative medicine experts join the Medicine by Design community through the New Investigators program
Three investigators join a cohort of 15 faculty members who have been supported by Medicine by Design’s New Investigators program.
Disabling age-related triggers of heart disease
Research team looks to blood for answers on why aging can cause inflammation and disease
Medicine by Design-funded scientists discover a new stem cell property that could enhance life-saving blood stem cell transplants
Researchers say the findings lay groundwork that could lead to methods for expanding stem cell numbers from donated cord blood biobanks to improve availability for people with leukemia.
Mapping out the mystery of blood stem cells
Using state-of-the art sequencing technology, Medicine by Design-funded scientists have revealed how stem cells are able to generate new blood cells throughout our life, and how these same cellular mechanisms can evade chemotherapy to survive and cause relapse many years later.
Medicine by Design seeds two strategic projects: An international partnership with the University of Cambridge and a new forum that will foster collaboration between clinicians, scientists and industry
$300,000 investment will accelerate new therapies and create new research tools.